Open AccessRelationship between circulating FGF23 and total body atherosclerosis in the community
Author(s) -
Majd A.I. Mirza,
Tomas Hansen,
Lars Johansson,
Håkan Åhlström,
Anders Larsson,
Lars Lind,
Tobias E. Larsson
Publication year - 2009
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfp205
Subject(s) - medicine , fibroblast growth factor 23 , odds ratio , kidney disease , cohort , calcinosis , calcification , endocrinology , gastroenterology , calcium , parathyroid hormone
Fibroblast growth factor-23 (FGF23) is a regulator of mineral metabolism and has been suggested to play a role in vascular calcification in chronic kidney disease (CKD). Data on the association between FGF23 and atherosclerosis, both in CKD and in the community, is limited.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom